Safety and Efficacy of the Contact Activation Inhibitor AB023 in Patients with End-Stage Renal Disease on Chronic Hemodialysis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial
答案Answerball
1个月前
93
10
已完结
1. 系统已在2026-04-22 10:48:39对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1182/blood-2020-139948
其他信息:
出版社: American Society of Hematology
作者: Christina U Lorentz; Norah G Verbout; Joseph J Shatzel; Michael Wallisch; Brandon D Markway; Monica T Hinds; Owen J T McCarty; David Gailani; Jeffrey I. Weitz; Erik I Tucker; András Gruber
全文下载地址: https://ashpublications.org/blood/article/136/Supplement%201/23/469854/Safety-and-Efficacy-of-the-Contact-Activation
